Therapeutic effects of lysophosphatidylcholine in experimental sepsis (Q28238163)

0 references

Jung-Eun Lee

0 references

Jongho Lee

0 references

Sung-Oh Huh

0 references

Hee-Sung Kim

0 references

Kyeong Cheon Jung

0 references

Jae-Young Cho

0 references

Ju-Suk Nam

0 references

Hong-Won Suh

0 references

Yung-Hi Kim

0 references

Dong-Keun Song

Complement-induced impairment of innate immunity during sepsis

0 references

language of work or name

English

0 references

publication date

February 2004

0 references

0 references

0 references

0 references

161-7

0 references

cites work

1 reference

7 January 2021

Protective effects of C5a blockade in sepsis

1 reference

7 January 2021

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment

1 reference

7 January 2021

Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans

1 reference

7 January 2021

The pathophysiology and treatment of sepsis

1 reference

7 January 2021

Sir Isaac Newton, sepsis, SIRS, and CARS

1 reference

7 January 2021

Protective effects of anti-C5a peptide antibodies in experimental sepsis

1 reference

7 January 2021

Prevention of lymphocyte cell death in sepsis improves survival in mice

1 reference

7 January 2021

Lysophosphatidylcholine as a ligand for immunoregulation

1 reference

7 January 2021

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

1 reference

7 January 2021

Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes

1 reference

7 January 2021

Lysophosphatidylcholine induces the production of IL-1beta by human monocytes

1 reference

7 January 2021

Mature dendritic cell generation promoted by lysophosphatidylcholine

1 reference

7 January 2021

Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages

1 reference

7 January 2021

Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages

1 reference

7 January 2021

Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions

1 reference

7 January 2021

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

1 reference

7 January 2021

Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation

1 reference

7 January 2021

Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes

1 reference

7 January 2021

Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes.

1 reference

7 January 2021

Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C

1 reference

7 January 2021

Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation.

1 reference

7 January 2021

Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils

1 reference

7 January 2021

Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium

1 reference

7 January 2021

RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

1 reference

7 January 2021

Leukocyte activation in sepsis; correlations with disease state and mortality

1 reference

7 January 2021

Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4

1 reference

7 January 2021

Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells

1 reference

7 January 2021

Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.

1 reference

7 January 2021

Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis

1 reference

7 January 2021

Interleukin-12 prevents diaphragm muscle deterioration in a septic animal model

1 reference

7 January 2021

Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality

1 reference

7 January 2021

Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients

1 reference

7 January 2021

Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target

1 reference

7 January 2021

An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma

1 reference

7 January 2021

The separation of the granulocytes from different rat strains. A comparative study

1 reference

7 January 2021

A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM989

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

14716308

1 reference

Consolidated OpenCitations Corpus – April 2017